Ruiz, PilarCausse, ManuelVaquero, ManuelCasal, Manuel2025-01-072025-01-072019-03-27https://hdl.handle.net/10668/25536Tedizolid is a novel oxazolidinone with activities against Gram-positive microorganisms, including mycobacteria. We studied the in vitro activity of tedizolid against 120 Mycobacterium tuberculosis strains, including susceptible, first-line-resistant, and multidrug-resistant isolates. MIC was tested using the Bactec 960 MGIT system. MIC90 and MIC50 were 0.5 and 0.25 μg/ml, respectively, in susceptible and resistant strains. Tedizolid may be an alternative in the treatment of resistant M. tuberculosis.enMycobacterium tuberculosisresistancetedizolidAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialHumansMicrobial Sensitivity TestsMycobacterium tuberculosisOxazolidinonesTetrazolesTuberculosisresearch article30670412open access10.1128/AAC.01939-181098-6596PMC6437524https://aac.asm.org/content/aac/63/4/e01939-18.full.pdfhttps://pmc.ncbi.nlm.nih.gov/articles/PMC6437524/pdf